Get in Touch



SI-5598

Refametinib, >98% (HPLC)

CAS No. : 
[923032-37-5]    
MDL No. : 
MFCD18633256
Synonyms : (S)-N-(3,4-Difluoro-2-((2-fluoro-4-iodophenyl)amino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide; BAY 869766; RDEA119

Price and Availability
Pack Size Price in USD Quantity Availability Shipping Status
10MG90.00 Back Order Estimated to Ship on 01.20.2025
25MG180.00 Back Order Estimated to Ship on 01.20.2025
50MG280.00 Back Order Estimated to Ship on 01.20.2025
100MG480.00 Back Order Estimated to Ship on 01.20.2025
250MG980.00 Back Order Estimated to Ship on 01.20.2025
Chemical Properties
C19H20F3IN2O5S 572.34
Solid Not available
For Laboratory research use only, not for drug, household or other uses.
Applications : Refametinib is an orally available, potent, non-ATP-competitive, selective, allosteric MEK1/MEK2 inhibitor with potential antineoplastic activity.
References : Iverson C. et al.: Cancer Res., 69(17), 6839-47, 2009.
Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.
Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

To receive price and delivery information on larger quantities, please complete the form below and we will respond promptly.

If you login prior to completion of the form, your contact information will automatically populate.

Your request for quote will also be accepted by e-mail at sales@syninnova.com or Fax: +1 780 485 2963.

Product ID : SI-5598

Product Name : Refametinib

Note : If you do not find your required compound in our catalogue, or not commercially available, please contact us, we will assist you to get your desired molecule. We only charge if we deliver to your satisfaction.

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!